Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer.
Mike WenzelNele WagnerBenedikt HoehCarolin SiechFlorestan KollCristina Cano GarciaMarit AhrensDerya TilkiThomas SteuberMarkus GraefenSéverine BanekFelix K H ChunPhilipp MandelPublished in: The Prostate (2024)
Significant differences exist between different metastatic patterns of HV and LV and HR and LR criteria. Best prognosis is observed within M1a LV and LR mHSPC patients.
Keyphrases
- prostate cancer
- lymph node
- squamous cell carcinoma
- small cell lung cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- radical prostatectomy
- type diabetes
- insulin resistance
- neoadjuvant chemotherapy
- bone mineral density
- body composition
- adipose tissue
- postmenopausal women
- sentinel lymph node
- bone loss